RC11C3, Pilot Placebo-controlled Evaluation of Pregabalin as a Means to Prevent the Paclitaxel-Associated Acute Pain Syndrome
Phase of Trial: Phase II
Latest Information Update: 08 Apr 2018
At a glance
- Drugs Pregabalin (Primary)
- Indications Acute pain
- Focus Therapeutic Use
- 20 Jul 2016 Status changed from active, no longer recruiting to completed.
- 11 Mar 2015 Planned primary completion date changed from 1 Nov 2014 to 1 Dec 2015, according to ClinicalTrials.gov record (NCT01637077).
- 16 Jul 2012 New trial record